[Zurück]
 
Bitte auswählen
Jahr
Details
Sprache
Sortierung
Ausgabe
neu: RTF !
 Forschungsbericht für das Jahr 2017

Studienzentrum des Universitätsklinikums Freiburg

(ehemals ZKS)

Elsässerstr. 2
79110 Freiburg
Tel: +49 - 761 270-77780 Fax: +49 - 761 270 73770
Email studienzentrum@uniklinik-freiburg.de
http://www.studienzentrum.uniklinik-freiburg.de


Einträge in der Rubrik "Who is Who"

Wissenschaftliche Publikationen

Originalarbeiten in wissenschaftlichen Fachzeitschriften:
  • Andrlova H, Mastroianni J, Madl J, Kern JS, Melchinger W, Dierbach H, Wernet F, Follo M, Technau-Hafsi K, Has C, Rao Mittapalli V, Idzko M, Herr R, Brummer T, Ungefroren H, Busch H, Boerries M, Narr A, Ihorst G, Vennin C, Schmitt-Graeff A, Minguet S, Timpson P, Duyster J, Meiss F, Romer W, Zeiser R: Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-beta1 expression. Oncotarget, 2017; 8 (26): 42901-42916. : http://dx.doi.org/10.18632/oncotarget.17160
  • Duiverman ML, Maagh P, Magnet FS, Schmoor C, Arellano-Maric MP, Meissner A, Storre JH, Wijkstra PJ, Windisch W, Callegari J: Impact of High-Intensity-NIV on the heart in stable COPD: a randomised cross-over pilot study. Resp Res, 2017; 18 (1): 76-76. : http://dx.doi.org/10.1186/s12931-017-0542-9
  • Engelhardt M, Domm AS, Dold SM, Ihorst G, Reinhardt H, Zober A, Hieke S, Baayen C, Muller SJ, Einsele H, Sonneveld P, Landgren O, Schumacher M, Wasch R: A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients. Haematologica, 2017; 102 (5): 910-921. : http://dx.doi.org/10.3324/haematol.2016.162693
  • Engelhardt M, Selder R, Pandurevic M, Moller M, Ihorst G, Waldschmidt J, Herget G, Wasch R: [Multidisciplinary Tumor Boards: Facts and Satisfaction Analysis of an Indispensable Comprehensive Cancer Center Instrument]. Deut Med Wochenschr, 2017; 142 (9): e51-e60. : http://dx.doi.org/10.1055/s-0043-100054
  • Finke J, Schmoor C, Bethge WA, Ottinger H, Stelljes M, Volin L, Heim D, Bertz H, Grishina O, Socie G: Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial. Lancet Haematol, 2017; 4 (6): e293-e301. : http://dx.doi.org/10.1016/S2352-3026(17)30081-9
  • Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Mohle R, Low S, Binder M, Atta J, Keller U, Wolf HH, Krause SW, Hess G, Naumann R, Sasse S, Hirt C, Lamprecht M, Martens U, Morgner A, Panse J, Frickhofen N, Roth A, Hader C, Deckert M, Fricker H, Ihorst G, Finke J, Illerhaus G: High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). Leukemia, 2017; 31 (4): 846-852. : http://dx.doi.org/10.1038/leu.2016.334
  • Greil C, Kiote-Schmidt C, Fink G, Ihorst G, Hildenbeutel S, Bosse R, Duyster J, Engelhardt M, Wasch R: Successful peripheral blood stem cell mobilization with a cost-efficient single fixed-dose plerixafor schedule in poor mobilizers. Leuk Lymphoma, 2017; 58 (8): 1849-1858. : http://dx.doi.org/10.1080/10428194.2016.1271946
  • Grohmann J, Wildberg C, Zartner P, Abu-Tair T, Tarusinov G, Kitzmuller E, Schmoor C, Stiller B, Kampmann C: Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients. Catheter Cardio Inte, 2017; 89 (7): E226-E232. : http://dx.doi.org/10.1002/ccd.26881
  • Hiller JK, Schmoor C, Gaidzik VI, Schmidt-Salzmann C, Yalcin A, Abdelkarim M, Blagitko-Dorfs N, Dohner K, Bullinger L, Duyster J, Lubbert M, Hackanson B: Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy. Ann Hematol, 2017; 96 (4): 559-565. : http://dx.doi.org/10.1007/s00277-016-2912-7
  • Kaier K, Reinecke H, Schmoor C, Frankenstein L, Vach W, Hehn P, Zirlik A, Bode C, Zehender M, Reinohl J: Learning Curves Among All Patients Undergoing Transcatheter Aortic Valve Implantation in Germany: A Retrospective Observational Study. Int J Cardiol, 2017; 235: 17-21. : http://dx.doi.org/10.1016/j.ijcard.2017.02.138
  • Lubbert M, Ihorst G, Sander PN, Bogatyreva L, Becker H, Wijermans PW, Suciu S, Bisse E, Claus R: Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5-aza-2'-deoxycytidine (Decitabine). Brit J Haematol, 2017; 176 (4): 609-617. : http://dx.doi.org/10.1111/bjh.14463
  • Magnet FS, Callegari J, Dieninghoff D, Spielmanns M, Storre JH, Schmoor C, Windisch W: Impact of Pseudomonas aeruginosa Infection on Respiratory Muscle Function in Adult Cystic Fibrosis Patients. Respiration, 2017; 93 (1): 42-50. : http://dx.doi.org/10.1159/000452893
  • Magnet FS, Majorski DS, Callegari J, Schwarz SB, Schmoor C, Windisch W, Storre JH: Capillary PO2 does not adequately reflect arterial PO2 in hypoxemic COPD patients. Int J Chronic Obstr, 2017; 12: 2647-2653. : http://dx.doi.org/10.2147/COPD.S140843
  • Schwarz SB, Windisch W, Magnet FS, Schmoor C, Karagiannidis C, Callegari J, Huttmann SE, Storre JH: Continuous non-invasive PCO2 monitoring in weaning patients: Transcutaneous is advantageous over end-tidal PCO2. Respirology, 2017; 22 (8): 1579-1584. : http://dx.doi.org/10.1111/resp.13095
  • Speckmann C, Doerken S, Aiuti A, Albert MH, Al-Herz W, Allende LM, Scarselli A, Avcin T, Perez-Becker R, Cancrini C, Cant A, Di Cesare S, Finocchi A, Fischer A, Gaspar HB, Ghosh S, Gennery A, Gilmour K, Gonzalez-Granado LI, Martinez-Gallo M, Hambleton S, Hauck F, Hoenig M, Moshous D, Neven B, Niehues T, Notarangelo L, Picard C, Rieber N, Schulz A, Schwarz K, Seidel MG, Soler-Palacin P, Stepensky P, Strahm B, Vraetz T, Warnatz K, Winterhalter C, Worth A, Fuchs S, Uhlmann A, Ehl S: A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis. J Allergy Clin Immun, 2017; 139 (4): 1302-1310.e4. : http://dx.doi.org/10.1016/j.jaci.2016.07.040
  • Strussmann T, Fritsch K, Baumgarten A, Fietz T, Engelhardt M, Mertelsmann R, Ihorst G, Duyster J, Finke J, Marks R: Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of Brit J Haematol, 2017; 178 (6): 927-935. : http://dx.doi.org/10.1111/bjh.14802
  • Tinsel I, Siegel A, Schmoor C, Buchholz A, Niebling W: DECADE-pilot: decision aid, action planning, and follow-up support for patients to reduce the 10-year rist of cardiovascular diseases - a protocol of a randomized controlled pilot trial Pilot and Feasibility Studies, 2017; 3 (1) (online).
  • Verhaart IEC, Robertson A, Leary R, McMacken G, Konig K, Kirschner J, Jones CC, Cook SF, Lochmuller H: A multi-source approach to determine SMA incidence and research ready population. J Neurol, 2017 (online). : http://dx.doi.org/10.1007/s00415-017-8549-1
  • Wuensch A, Goelz T, Ihorst G, Terris DD, Bertz H, Bengel J, Wirsching M, Fritzsche K: Effect of individualized communication skills training on physicians' discussion of clinical trials in oncology: results from a randomized controlled trial. Bmc Cancer, 2017; 17 (1): 264-264. : http://dx.doi.org/10.1186/s12885-017-3238-0
  • Zens M, Grotejohann B, Tassoni A, Duttenhoefer F, Sudkamp NP, Niemeyer P: Development of a Modular Research Platform to Create Medical Observational Studies for Mobile Devices. JMIR Res Protoc, 2017; 6 (5): e99-e99. : http://dx.doi.org/10.2196/resprot.7705
Konferenzbeiträge:
  • Fuellgraf H, Haug S, Kiefer S, Schmid S, Wang Y, Schneider D, Boeker M, Bredenkamp R, Bronsert P, Werner M: Implementation of Automised Import of Patient Consent Form for Biobanking 101. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V., 2017; A-526 (101. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V.).
  • Köhler M, Surlan I, Schulz A, Altindis-Gürlü M, Angerer R, Bierenstiel S, Bubritzki S, Falahen M, Höfflin M, Jakobs D, Kappes S, Karaaslan C, Meisenzahl J, Messner C, Pfaller S, Singer N, Souchon S, Ullrich A, Wenske S, Wisser B, Kiote-Schmidt C, Rummelt C, Schnerch D, Dorn F, Rettig A, Ajayi S, Otte P, Reinhardt H, Szymaniak-Vits M, Bertz H, von Bubnoff N, Dierks C, Finke J, Fritsch R, Heinz J, Lübbert M, Marks R, Rawluk J, Waller C, Zeiser R, Ruch M, Boeker M, Bredenkamp R, Duyster J, Wäsch R, Illerst L, Engelhardt M: Early Clinical Trial Unit (ECTU) and entire Clinical Trial (CT) activities in hematology & oncology (H&O) supported by the Clinical Cancer Research (CCR-) Group and Comprehensive Cancer Center (CCCF) role model for others Oncol Res Treat, 2017.

Besondere wissenschaftliche Aktivitäten

Abschlussarbeiten